Short- and Long-Term Mortality After Myocardial Infarction in Patients With and Without Diabetes Featured Article: Sjoerd T. Nauta, M.S.C., Jaap W. Deckers,

Slides:



Advertisements
Similar presentations
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Advertisements

Foos et al, EASD, Lisbon, 13 September 2011 Comparison of ACCORD trial outcomes with outcomes estimated from modelled and meta- analysis studies Volker.
Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity Featured Article: Ricardo V. Cohen, M.D., Jose C. Pinheiro, M.D.,
Valsartan Antihypertensive Long-Term Use Evaluation Results
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Clinical Trial Results. org Based on the Iron (Fe) and Atherosclerosis Study (FeAST) Leo R. Zacharski, MD; Bruce K. Chow, MS; Paula S. Howes, MS, APRN;
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
Journal Club Alcohol and Health: Current Evidence March-April 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
Severe Hypoglycemia and Mortality After Cardiovascular Events for Type 1 Diabetic Patients in Sweden Featured Article: Tom W.C. Lung, Dennis Petrie, William.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-
VBWG IDEAL: The Incremental Decrease in End Points Through Aggressive Lipid Lowering Study.
Individualizing Targets and Tactics for High- Risk Patients With Type 2 Diabetes Practical lessons from ACCORD and other cardiovascular trials Featured.
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
ACTIVE Clopidogrel plus Aspirin versus Aspirin in Patients Unsuitable for Warfarin.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Silent Ischemia STABLE CAD
Published in Circulation 2003 Rory Hachamovitch, MD, MSc; Sean W. Hayes, MD; John D. Friedman, MD; Ishac Cohen PhD; Daniel S. Berman, MD Comparison of.
Association of C-Reactive Protein and Acute Myocardial Infarction in HIV-Infected Patients Virginia A. Triant, MD, MPH, James B. Meigs, MD, MPH, and Steven.
Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 diabetes is more hazardous and lethal than type 1 diabetes Featured Article: Maria.
Heart failure and comorbidities
Secondary prevention of a Recurrent ACS; Results from the 2004 & 2006 ACSIS Survey Perl L, Behar S, Schwartz R, Mosseri M Meir Hospital and Sheba Tel Hashomer,
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Evaluation of Current Eligibility Criteria for Bariatric Surgery Diabetes prevention and risk factor changes in the Swedish Obese Subjects (SOS) study.
Trial profile Prakash Deedwania, et al. Lancet 2006; 368:
Clinical and Economic Benefits Associated With the Achievement of Both HbA1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes Featured Article:
Trends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006 Featured Article: Edward W. Gregg, Ph.D., Yiling J. Cheng, Ph.D.,
Mortality After Incident Cancer in People With and Without Type 2 Diabetes Featured Article: Craig J. Currie, Ph.D., Chris D. Poole, Ph.D., Sara Jenkins-Jones,
Date of download: 5/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparative Effectiveness of Rhythm Control vs Rate.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prevalence and Clinical Implications of Newly Revealed,
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Christopher P. Cannon, M. D. , Eugene Braunwald, M. D. , Carolyn H
Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:
LEADER trial: Primary Outcome
Copyright © 2006 American Medical Association. All rights reserved.
Copyright © 2009 American Medical Association. All rights reserved.
Effect of Obesity on In-Hospital Mortality in Patients with Cardiogenic Shock Complicating AMI Obesity is paradoxically associated with favorable mortality.
Volume 84, Issue 2, Pages (August 2013)
Renal function and outcome after heart transplantation
Baseline characteristics of patients
Relative risk of major events with atenolol vs placebo
Impact of Statins on Physical Activity and Fitness: Ally or Adversary?
Diabetes Journal Club March 17, 2011
P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Figure 4 Observational studies on multiple treatment strategies
Volume 383, Issue 9925, Pages (April 2014)
Mancini JG, et al. Am J Cardiol.
Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.
Volume 392, Issue 10144, Pages (July 2018)
Gender differences in diabetes prevalence in 2009 in the general Portuguese population patients and in patients with CAP. Diabetes prevalence is higher.
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Patient characteristics: American vs Canadian transplant patients
International Journal of Cardiology
Age-dependent care and long-term (20year) mortality of 14,434 myocardial infarction patients: Changes from 1985 to 2008  Sjoerd T. Nauta, Jaap W. Deckers,
Weekend versus weekday mortality in ST-segment elevation acute myocardial infarction patients between 1985 and 2008  Sanne M. Snelder, Sjoerd T. Nauta,
Admission Glucose and In-hospital Mortality after Acute Myocardial Infarction in Patients with or without Diabetes: A Cross-sectional Study Shi Zhao, Karthik.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
EMPA-REG OUTCOME: Cumulative incidence of the primary outcome
The benefit of evolocumab treatment is consistent regardless of inflammation level HR %CI ARR 1.6% 1.8%
Christian Madelaire et al. JCHF 2018;6:
Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Temporal trends of AF hospitalisation per 100 patients with AF according to main hospitalisation causes between 2006 and *P value for increase trends 
The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.
Presentation transcript:

Short- and Long-Term Mortality After Myocardial Infarction in Patients With and Without Diabetes Featured Article: Sjoerd T. Nauta, M.S.C., Jaap W. Deckers, M.D., Ph.D., K. Martijn Akkerhuis, M.D., Ph.D., Ron T. Van Domburg, Ph.D. Diabetes Care Volume 35: October, 2012

STUDY OBJECTIVE To study temporal trends in short- and long-term outcome after myocardial infarction (MI) according to diabetes status Nauta S T et al. Diabetes Care 2012;35:

STUDY DESIGN AND METHODS 14,434 consecutive patients admitted for ST-segment elevation MI or non–ST-segment elevation MI between 1985 and 2008 Patients compared according to prevalent diabetes Temporal trend analyses performed by comparing decades of admission (1985–1989 vs. 1990–1999 vs. 2000–2008) Nauta S T et al. Diabetes Care 2012;35:

RESULTS 2,015 (14%) of patients had prevalent diabetes Risk of presenting with diabetes increased from 8 to 17% from 1985 to 2008 Diabetic patients presented with a higher prevalence of cardiovascular risk factors Use of evidence-based therapies increased in both patients with and without diabetes Nauta S T et al. Diabetes Care 2012;35:

RESULTS Diabetes associated with a 1.5-fold increased risk of mortality at the 20-year follow-up 10-year mortality decreased over time in patients with diabetes, from 53% in 1985–1989 to 39% in 2000–2008 (adjusted hazard ratio 0.56 [95% CI 0.43–0.73]), and in those without diabetes, from 38% in 1985–1989 to 29% in 2000–2008 (0.66 [0.60–0.73]; P interaction = 0.83) Patients with diabetes benefitted from a higher 30-day and 10-year absolute survival increase Nauta S T et al. Diabetes Care 2012;35:

CONCLUSIONS Temporal mortality reductions after MI between 1985 and 2008 were at least as high in patients with diabetes compared with those without diabetes Long-term mortality remained higher in diabetic patients Awareness of the high-risk profile of diabetic patients is warranted and might stimulate optimal medical care and outcome Nauta S T et al. Diabetes Care 2012;35: